Related Experiment Video
Updated: Jul 1, 2026

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
Published on: July 11, 2016
Rhodotorula infection. A systematic review of 128 cases from literature
Felipe F Tuon1, Silvia F Costa
1Department of Infections and Parasitic Diseases, School of Medicine, University of São Paulo, Brazil. flptuon@gmail.com.br
Abstract:
Rhodotorula is an emerging opportunistic pathogen, particularly in immunocompromised patients. Many cases of fungemia associated with catheters, endocarditis, peritonitis, meningitis, and endophthalmitis are infections incited by this yeast. The main purpose of this study was to review all cases of Rhodotorula infection reported in the literature and to describe risk factors, underlying conditions and outcome. From 128 cases, 79% were fungemia (103 cases), 7% eye infections (nine cases) and 5% (six cases) peritonitis associated with continuous ambulatory peritoneal dialysis. Eighty seven percent of Rhodotorula infections are associated with underlying immunosuppression or cancer. The most common isolated risk factor associated with Rhodotorula infection was the use of a central venous catheter, which was found in 83.4% of Rhodotorula fungemia (86 cases). Rhodotorula mucilaginosa was the most common species of fungemia (74% of cases), followed by Rhodotorula glutinis with 7.7%. The species was not identified in 17% of the cases of fungemias. Amphotericin was the drug of choice in the treatment of fungemia and most of the eye infections were treated with topical amphotericin, although all patients lost their vision. All peritonitis cases associated with continous ambulatory peritoneal dialysis needed to have the Tenckoff catheter changed. The overall mortality of Rhodotorula infection was 12.6%.
Insights
Rhodotorula infections, often in immunocompromised patients, commonly present as fungemia linked to central venous catheters. Amphotericin is the primary treatment, but mortality remains significant.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Rhodotorula is an emerging opportunistic fungal pathogen.
- It poses a significant risk to immunocompromised individuals.
- Rhodotorula infections can manifest as fungemia, endocarditis, peritonitis, meningitis, and endophthalmitis.
Purpose of the Study:
- To comprehensively review reported cases of Rhodotorula infection.
- To identify associated risk factors, underlying conditions, and patient outcomes.
- To analyze the epidemiology and clinical characteristics of Rhodotorula infections.
Main Methods:
- Systematic literature review of Rhodotorula infection cases.
- Data extraction on patient demographics, clinical presentation, risk factors, and treatment.
- Analysis of infection types, causative species, and mortality rates.
Main Results:
- The study reviewed 128 cases; 79% were fungemia, 7% eye infections, and 5% peritonitis.
- Eighty-seven percent of infections occurred in immunocompromised or cancer patients.
- Central venous catheter use was the primary risk factor (83.4% of fungemia cases).
- Rhodotorula mucilaginosa was the most common species (74% of fungemia).
- Amphotericin was the preferred treatment; topical amphotericin was used for eye infections with complete vision loss.
- Peritonitis cases required Tenckoff catheter removal.
- Overall mortality was 12.6%.
Conclusions:
- Rhodotorula infections are serious, particularly in immunocompromised hosts, with fungemia being the most common presentation.
- Central venous catheters are a major risk factor, highlighting the need for preventative measures.
- While Amphotericin remains a key treatment, outcomes can be severe, necessitating further research into management strategies.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Bacterial Phylum Spirochaetes
Cholera
Bacterial Phylum Bacteroidota
Diversity of Protists III